GHK-Cu and skin claims: what the evidence supports

A recent TikTok from a hair and wellness creator claims that waking up at 2–3 AM every night is not random but is linked to hormones, and that certain peptides can support deeper, more restorative sleep. The video invites viewers to DM for a free guide, but the underlying claim—that peptides are a solution for middle-of-the-night waking in perimenopause—deserves a closer look at the research landscape.

What the clip is claiming

The creator implies that nighttime awakenings are a direct hormonal signal and that peptides can address this issue. While perimenopause does involve fluctuating estrogen and progesterone, which can affect sleep architecture, the leap to peptides as a targeted fix is an oversimplification. The clip does not specify which peptides, nor does it mention dosages, cycles, or potential side effects.

What the research neighborhood actually covers

Peptides studied for sleep and hormonal support include those that influence the hypothalamic-pituitary axis. For example, Ipamorelin and CJC-1295 (with or without DAC) are growth hormone secretagogues that may improve sleep quality indirectly by increasing slow-wave sleep. GHK-Cu, while primarily known for skin and wound healing, has been investigated for its anti-inflammatory and antioxidant properties, which could theoretically support overall wellness but not directly sleep. DSIP (Delta Sleep-Inducing Peptide) is another compound that has been researched for its role in sleep regulation, though human data are limited.

Limits, missing context, and what a 15-second clip cannot show

A short video cannot convey the complexity of sleep disturbances in perimenopause. Hormonal changes are only one factor; stress, lifestyle, and underlying sleep disorders (e.g., sleep apnea) are equally important. Moreover, the research on peptides for sleep is mostly preclinical or small-scale. For instance, DSIP has shown mixed results in human trials, and its clinical use is not established. The clip also omits that peptides are research-use only (RUO) and not approved for human consumption by regulatory agencies.

How this maps to named research compounds

If the clip is about peptides for sleep, the catalog compounds most relevant are DSIP, Ipamorelin, and CJC-1295 (both with and without DAC). GHK-Cu is often mentioned in wellness contexts but is not a sleep peptide. BPC-157 and TB-500 are more associated with tissue repair and inflammation, not sleep. The creator’s vague reference to “peptides” does not align with a specific compound, so it is impossible to verify the claim against a single peptide’s evidence base.

Research-use caveat

All peptides discussed here are intended for laboratory research only. They are not approved for medical use, and any human consumption is not recommended. The FDA has not evaluated these compounds for safety or efficacy. Always consult a healthcare provider for sleep issues.

Open the full video fact-check page (transcript, takeaways, embedded clip).